September 21, 2022 | Statement from Health GAP Executive Director Asia Russell on the Seventh Replenishment Conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria
July 28, 2022 | Health GAP Statement regarding ViiV - MPP Voluntary Licensing Agreement for CAB-LA
July 27, 2022 | As the International AIDS Conference Kicks Off in Montreal, New UNAIDS Global AIDS Update Shows Deadly Backsliding Away From Ending the Pandemic, With AIDS Deaths No Longer Declining
July 22, 2022 | Statement from Health GAP
June 17, 2022 | Statement from Asia Russell, Health GAP Executive Director, on the Failure of the WTO’s MC12 to Deliver a TRIPS Waiver for COVID-19 Vaccines, Treatments, and Tests
May 04, 2022 | Campaigners protest GSK for pricing game-changing HIV prevention medication 100 times more expensive than gold, blocking global access
April 20, 2022 | 109 Civil Society Organizations Call on Dominican Republic President Luis Abinader to Support Compulsory License to Expand Access and Break Pfizer’s Monopoly Over Lifesaving COVID-19 Treatment
April 04, 2022 | Long-Acting PreP is a Necessity, Not a Luxury: ViiV’s Greed is Still Blocking Global Access to Injection that Could Transform HIV Prevention and Help End the Pandemic
March 29, 2022 | Biden’s PEPFAR Funding Cuts Put People with HIV at Greater Risk
March 17, 2022 | Nearly 100 Health, Development and Human Rights Groups Write Pfizer CEO Demanding Immediate Action to Increase Access to COVID-19 Antivirals in Low- and Middle-Income Countries
